Protagenic Therapeutics Inc

NASDAQ:PTIX  
1.75
-0.07 (-3.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Protagenic Therapeutics Inc Stock, NASDAQ:PTIX

149 Fifth Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8200
Number of Employees: 2

Description

Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.